HIV治療薬の世界市場予測および分析...市場調査レポートについてご紹介

【英文タイトル】PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2023

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 11
1.1 List of Tables 19
1.2 List of Figures 26
2 Introduction 28
2.1 Catalyst 28
2.2 Related Reports 29
2.3 Upcoming Related Reports 29
3 Disease Overview 30
3.1 Etiology 30
3.1.1 Viral Lifecycle 30
3.2 Pathophysiology 33
3.3 Staging and Symptoms 34
3.3.1 Primary or Acute Infection 34
3.3.2 Chronic Infection 35
3.3.3 Advanced Infection/AIDS 35
3.4 Prognosis 37
3.5 Quality of Life 37
4 Epidemiology 39
4.1 Disease Background 39
4.2 Risk Factors and Comorbidities 39
4.3 Global Trends 41
4.3.1 US 42
4.3.2 5EU 42
4.3.3 Brazil, China, and Japan 43
4.4 Forecast Methodology 44
4.4.1 Sources Used 45
4.4.2 Sources Not Used 55
4.4.3 Forecast Assumptions and Methods 56
4.5 Epidemiological Forecast for HIV in the 8MM (2013-2023) 62
4.5.1 Total Prevalent Cases of HIV 62
4.5.2 Age-Specific Total Prevalent Cases of HIV 64
4.5.3 Sex-Specific Total Prevalent Cases of HIV 66
4.5.4 Age-Standardized Total Prevalence of HIV 68
4.5.5 HIV Cases Treated with ART 69
4.5.6 Cases of HIV in Pregnant Women 70
4.6 Epidemiological Forecast for HIV in Japan (2013-2023) 71
4.6.1 20-Year Diagnosed Prevalent Cases of HIV 71
4.6.2 Age-Specific 20-Year Diagnosed Prevalent Cases of HIV 72
4.6.3 Sex-Specific 20-Year Diagnosed Prevalent Cases of HIV 73
4.6.4 Age-Standardized 20-Year Diagnosed Prevalence of HIV 74
4.6.5 HIV Cases Treated with ART 75
4.6.6 Cases of HIV in Pregnant Women 76
4.7 Discussion 76
4.7.1 Epidemiological Forecast Insight 76
4.7.2 Limitations of the Analysis 77
4.7.3 Strengths of the Analysis 78
5 Disease Management 79
5.1 Diagnosis and Treatment Overview 79
5.1.1 Screening and Diagnosis 79
5.1.2 Treatment Guidelines and Leading Prescribed Drugs 80
5.1.3 Clinical Practice 82
5.2 US 92
5.2.1 Screening and Diagnosis 94
5.2.2 Clinical Practice 95
5.3 5EU 97
5.3.1 Screening and Diagnosis 98
5.3.2 Clinical Practice 99
5.4 Japan 103
5.4.1 Screening and Diagnosis 104
5.4.2 Clinical Practice 104
5.5 Brazil 107
5.5.1 Screening and Diagnosis 107
5.5.2 Clinical Practice 108
5.6 China 111
5.6.1 Screening and Diagnosis 111
5.6.2 Clinical Practice 112
6 Competitive Assessment 115
6.1 Overview 115
6.2 Product Profiles – Major Brands, Single-Tablet Regimens (STRs) 118
6.2.1 Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate) 118
6.2.2 Complera (emtricitabine/TDF/rilpivirine) 124
6.2.3 Stribild (elvitegravir/cobicistat/TDF/emtricitabine) 131
6.2.4 Triumeq (dolutegravir/abacavir/lamivudine) 139
6.3 Product Profiles – Major Brands, Fixed-Dose Combinations 147
6.3.1 Truvada (TDF/emtricitabine) 147
6.3.2 Epzicom (abacavir/lamivudine) 153
6.3.3 Kaletra (lopinavir/ritonavir) 158
6.3.4 Prezcobix (darunavir/cobicistat) 164
6.3.5 Evotaz (atazanavir sulfate/cobicistat) 169
6.4 Product Profiles – Major Brands, Protease Inhibitors 175
6.4.1 Reyataz (atazanavir) 175
6.4.2 Prezista (darunavir) 180
6.5 Product Profiles – Major Brands, Integrase Inhibitors 185
6.5.1 Isentress (raltegravir) 185
6.5.2 Tivicay (dolutegravir) 191
6.5.3 Vitekta (elvitegravir) 199
6.6 Product Profiles – Major Brands, Pharmacokinetic Enhancers 205
6.6.1 Norvir (ritonavir) 205
6.6.2 Tybost (cobicistat) 209
6.7 Other Therapeutic Classes 215
6.7.1 Entry Inhibitors 215
7 Unmet Need and Opportunity 216
7.1 Overview 216
7.2 Therapies with Improved Safety and Tolerability Profiles 218
7.2.1 Unmet Need 218
7.2.2 Gap Analysis 219
7.2.3 Opportunity 220
7.3 Simplified PI-Based ART Regimens with a Reduced Pill Burden 221
7.3.1 Unmet Need 221
7.3.2 Gap Analysis 222
7.3.3 Opportunity 223
7.4 Enhanced Public Awareness Initiatives Focused on Minimizing the Stigma Associated with HIV 224
7.4.1 Unmet Need 224
7.4.2 Gap Analysis 225
7.4.3 Opportunity 226
7.5 Improved Physician Education Tools That Emphasize the Importance of Early Testing and Diagnosis 226
7.5.1 Unmet Need 226
7.5.2 Gap Analysis 228
7.5.3 Opportunity 228
7.6 Safe and Efficacious Therapies for Patients with Drug-Resistant HIV Strains 228
7.6.1 Unmet Need 228
7.6.2 Gap Analysis 229
7.6.3 Opportunity 230
7.7 Long-Acting Regimens That Require Less Frequent Administration 230
7.7.1 Unmet Need 230
7.7.2 Gap Analysis 231
7.7.3 Opportunity 232
7.8 Improved Access to Treatment 232
7.8.1 Unmet Need 232
7.8.2 Gap Analysis 233
7.8.3 Opportunity 233
7.9 Progress Towards a Functional Cure 234
7.9.1 Unmet Need 234
7.9.2 Gap Analysis 234
7.9.3 Opportunity 235
8 Pipeline Assessment 236
8.1 Overview 236
8.2 Clinical Trial Mapping 237
8.2.1 Clinical Trials by Country 237
8.3 Promising Drugs in Late-Stage Clinical Development 238
8.3.1 Quad 2 (elvitegravir/cobicistat/emtricitabine/TAF) 241
8.3.2 Darunavir/Cobicistat/Emtricitabine/TAF 252
8.3.3 Emtricitabine/TAF 261
8.3.4 Dutrebis (raltegravir/lamivudine) 269
8.3.5 Doravirine (MK-1439) 276
8.4 Promising Drugs in Early-Stage Clinical Development 284
8.5 Other Drugs in Clinical Development 287
9 Current and Future Players 289
9.1 Overview 289
9.2 Trends in Corporate Strategy 291
9.3 Company Profiles 293
9.3.1 Gilead Sciences 293
9.3.2 ViiV Healthcare 298
9.3.3 AbbVie 303
9.3.4 Merck & Co. 306
9.3.5 Janssen 310
9.3.6 Bristol-Myers Squibb 314
9.3.7 Japan Tobacco 319
9.3.8 Avexa 322
9.3.9 TaiMed Biologics 325
9.3.10 Tobira Therapeutics 327
10 Market Outlook 331
10.1 Global Markets 331
10.1.1 Forecast 331
10.1.2 Drivers and Barriers – Global Issues 337
10.2 United States 339
10.2.1 Forecast 339
10.2.2 Key Events 345
10.2.3 Drivers and Barriers 346
10.3 5EU 348
10.3.1 Forecast 348
10.3.2 Key Events 356
10.3.3 Drivers and Barriers 357
10.4 Japan 363
10.4.1 Forecast 363
10.4.2 Key Events 368
10.4.3 Drivers and Barriers 370
10.5 Brazil 372
10.5.1 Forecast 372
10.5.2 Key Events 377
10.5.3 Drivers and Barriers 378
10.6 China 380
10.6.1 Forecast 380
10.6.2 Key Events 384
10.6.3 Drivers and Barriers 385
11 Appendix 388
11.1 Bibliography 388
11.2 Abbreviations 422
11.3 Methodology 429
11.4 Forecasting Methodology 429
11.4.1 Total Prevalent Cases of HIV 429
11.4.2 20-Year Diagnosed Prevalent Cases of HIV 429
11.4.3 HIV Cases Treated with ART 430
11.4.4 Drugs Included in Each Therapeutic Class 431
11.4.5 Launch and Patent Expiry Dates 432
11.4.6 General Pricing Assumptions 433
11.4.7 Individual Drug Assumptions 435
11.4.8 Generic Erosion 453
11.4.9 Pricing of Pipeline Agents 453
11.5 Primary Research – KOLs Interviewed for This Report 455
11.6 Primary Research – Prescriber Survey 457
11.7 About the Authors 458
11.7.1 Analyst 458
11.7.2 Epidemiologists 458
11.7.3 Therapy Area Director 458
11.7.4 Global Director of Therapy Analysis and Epidemiology 459
11.7.5 Global Head of Healthcare 459
11.8 About GlobalData 460
11.9 Disclaimer 460


【レポート販売概要】

■ タイトル:HIV治療薬の世界市場予測および分析
■ 英文:PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2023
■ 発行日:2015年9月9日
■ 調査会社:GlobalData
■ 商品コード:GDHC94PIDR
■ 調査対象地域:グローバル
  • 高級家具の世界市場分析:材料別(木材、金属、ガラス、皮革、プラスチック)、エンドユーザー別(リビングルーム、ベッドルーム、キッチン、アウトドア、バスルーム、ホスピタリティ、オフィス)、セグメント予測
    Global luxury furniture market is expected to reach USD 28,600.7 million by 2022 growing at an estimated CAGR of 3.7% from 2015 to 2022, according to a new study by Grand View Research, Inc. This expected growth in demand can be ascribed to rapid urbanization and growing demand for home furnishings. Additionally, disposable income of individuals in North America and Asia-Pacific region has also wi …
  • 電子レンジ調理用食品の世界市場2019-2023
    About this market The availability of numerous distribution channels will trigger the market’s growth during the forecast period. Surging presence of supermarkets, hypermarkets, and specialty stores selling microwavable food is expected to gain prominence in the market. Vendors are selling their products through retailers including Walmart and Tesco.com. As a result, the easy availability of micro …
  • 萎縮性胃炎(Atrophic Gastritis):世界の治験レビュー(2015年上半期版)
    Atrophic Gastritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Atrophic Gastritis Global Clinical Trials Review, H1, 2015" provides data on the Atrophic Gastritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Atrophic Gastritis. It includes an overview of the trial numbers and their recruitme …
  • 世界の遺伝子治療薬パイプライン分析
    “Gene Therapy Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Pha …
  • 工場資産管理システムの世界市場2016-2020
    About Plant Asset Management System A PAM system manages and monitors the fixed assets of a company, which are used in the production process. PAM gives a better control over the production process and generates a real-time data of assets, which enables officials to take informed decision. The real-time data generated by a PAM system can also be used to identify signs of failure, ensuring that pla …
  • ナイジェリアの石油・ガス産業における中流(Midstream)市場展望
    Nigeria Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing Summary "Nigeria Midstream Oil and Gas Industry Outlook to 2020: Market Forecasts for Liquefied Natural Gas (LNG), Oil Storage, Pipelines and Gas Processing" is a comprehensive report on midstream oil and gas industry in Nigeria. The report provides oi …
  • 水性塗料の世界市場:樹脂別(アクリル、ポリウレタン、エポキシ、アルキド、ポリエステル、PTFE、PVDC、PVDF、その他)、用途別、地域別、セグメント予測
    The global waterborne coatings market is projected to reach USD 82.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at CAGR of 5.7% over the forecast period. The prices of raw materials used in manufacturing waterborne coatings are expected to have a significant impact on the production cost of the final product. The demand for these raw m …
  • 航空機用シートの世界市場予測及び分析
    The aircraft seating market is estimated to be USD 7.48 billion in 2015, and is projected to reach USD 14.82 billion by 2020, at a CAGR of 14.65% from 2015 to 2020. This report includes financial analysis of key players in the market, historical market analysis, technology trends, market environment analysis, and industry overview, which further includes supply chain analysis, value chain analysis …
  • MEMSインクジェットヘッドの世界市場2015-2019
    About MEMS Inkjet Heads Inkjet heads are an integral part of printers. There are two main types of printers: impact printers and non-impact printers. Impact printers, such as dot-matrix printers, use forceful impact to produce text and images on paper. They use print heads that strike the surface of ink ribbons, pressing these ribbons against the paper. On the other hand, non-impact printers, incl …
  • 産業用ヒートポンプの世界市場2019-2023
    Technavio Announces the Publication of its Research Report – Global Industrial Heat Pumps Market 2019-2023 Technavio recognizes the following companies as the key players in the global industrial heat pumps market: DAIKIN INDUSTRIES, Emerson Electric Co, Johnson Controls, Mitsubishi Electric Corporation, Robert Bosch GmbH, UNITED TECHNOLOGIES (Carrier). Commenting on the report, an analyst from Te …
  • ノイズ検出およびモニタリングの世界市場
    ABSTRACTAbout Noise Detection and Monitoring Noise detection and monitoring products include noise dosimeters, noise monitors, and sound meters, which are used to measure and monitor excessive noise to control the noise levels. Noise is one of the most common occupational hazards, and exposure to high noise level can create psychological stress, reduce productivity, and cause hearing disabilities. …
  • 塩化鉄(III)の世界市場2015-2019
    About ferric chloride Ferric chloride is used as a coagulant, mostly in the form of a liquid (40% solution), in the treatment of wastewater and sewage water (domestic and industrial). Ferric chloride is also used in PCB manufacturing. Industrially, ferric chloride is much more important than ferrous chloride. It is produced industrially by a reaction of dry chlorine with scrap iron (direct chlorin …
  • メキシコの滅菌器市場見通し(~2021)
    Mexico Sterilization Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Mexico Sterilization Equipment Market Outlook to 2021", provides key market data on the Mexico Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and U …
  • Diabetic Peripheral Neuropathy:治療薬のグローバル治験動向(2014年上半期)
    Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Peripheral Neuropathy. It includes an o …
  • 液体分析機器の世界市場:液体分析トランスミッタ、液体分析センサー、液体分析総合システム
    About Liquid Analytical Instruments Liquid analytical instruments are used for analyzing the characteristics of liquids and measuring the chemical composition of liquids. Liquid analytical instruments are widely used in several applications such as the measurement of potential of hydrogen, oxidation reduction potential, dissolved oxygen, and conductivity/resistivity of a liquid. These instruments …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。